Bladder (Urothelial, Transitional Cell) Cancer Clinical Trials
2 recruiting trials for Bladder (Urothelial, Transitional Cell) Cancer. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT07073703
Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer.
Bladder and kidney cancers are commonly diagnosed in older adults. Surgery remains the primary treatment modality for patients with kidney or bladder cancer. In older patients,...
Sponsor: Centre Hospitalier Universitaire de Saint EtienneEnrolling: 1062 locations
RECRUITINGPhase 2NCT06696742
PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma
This study intends to explore whether the combination of Clostridium butyricum can improve the current situation of poor anti-PD1 treatment effect in patients with bladder cancer.
Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 601 location